Erschienen in:
01.12.2016 | geriatrics: at crossroads of medicine
Publication trends in cachexia and sarcopenia in elderly heart failure patients
verfasst von:
PD Dr. Jochen Springer, Stefan D. Anker
Erschienen in:
Wiener klinische Wochenschrift
|
Sonderheft 7/2016
Einloggen, um Zugang zu erhalten
Summary
The loss of skeletal mass – sarcopenia and cachexia – is considered to be a major contributor to morbidity and mortality in chronic heart failure (CHF). Unfortunately, sarcopenia is generally considered to be a geriatric syndrome, but not necessarily seen as a comorbidity in CHF, even though it has a wide range of adverse health outcomes. While there were 15,574 publication with the title word “heart failure” in PubMed in the 5‑year period from 1 June 2011 to 31 May 2016, only 22 or 71 publications were found with the search combination “sarcopenia” or “cachexia” (title word) and “heart failure” (all fields), respectively. This shows very clearly that loss of muscle quality and function due to heart failure is still an underappreciated problem in the medical field.